Ledger.Open graph →
SEC Form D · filed April 11, 2016

AzurRx BioPharma, Inc

Offering
$12.0M
Sold
$635K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Brooklyn, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Alastair M. Riddell · Brooklyn, NYDirectorMaged M. Shenouda · Brooklyn, NYDirectorEdward M. Borkowski · Brooklyn, NYDirectorJohan (Thijs) Spoor · Brooklyn, NYExec · DirectorJeffrey B. Van Horn · New York, NYDirectorThomas Allison · New York, NYExec · DirectorJoseph M. Cugine · BEVERLY HILLS, CADirectorArnold M. Tinter · BEVERLY HILLS, CADirectorDennis Huang · NEWPORT BEACH, CADirectorTom Albright · NEWPORT BEACH, CADirectorDavid Ramsay · NEWPORT BEACH, CADirectorJonathan Lim, M.D · NEWPORT BEACH, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗